Please use this identifier to cite or link to this item: https://hdl.handle.net/10216/150632
Full metadata record
DC FieldValueLanguage
dc.creatorVicente, MM-
dc.creatorLeite-Gomes, E-
dc.creatorPinho, SS-
dc.date.accessioned2023-07-04T15:45:55Z-
dc.date.available2023-07-04T15:45:55Z-
dc.date.issued2023-
dc.identifier.issn1471-4906-
dc.identifier.urihttps://hdl.handle.net/10216/150632-
dc.description.abstractGlycans cover the surfaces of all mammalian cells through a process called glycosylation. Nearly all proteins and receptors that integrate the intricate series of co-stimulatory/inhibitory pathways of the immune system are glycosylated. Growing evidence indicates that the development of the immune system at the origins of T and B cell development is tightly regulated by glycosylation. In this opinion, we hypothesize that the glycome composition of developing T and B cells is developmentally regulated. We discuss how glycans play fundamental roles in lymphocyte development and how glycans early define T and B cell functionality in multiple aspects of adaptive immunity. These advances can provide opportunities for the discovery of novel disease factors and more effective candidate treatments for various conditions.pt_PT
dc.description.sponsorshipThis work was funded by the EU (ERC, GlycanSwitch, Grant Agreement N° 101071386). Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Council Executive Agency. Funded by the European Union (GlycanTrigger, Grant Agreement N°: 101093997. Views and opinions expressed are, however, those of the author(s) only and do not necessarily reflect those of the European Union or European Health and Digital Executive Agency. Neither the European Union nor the granting authority can be held responsible for them. M.M.V. and E.L-G. received funding from the Portuguese Foundation for Science and Technology (FCT) of the Portuguese Ministry of Science, Technology and Higher Education (M.M.V.: PD/BD/135452/2017, COVID/BD/152488/2022; E.L-G.: UI/BD/152866/2022).pt_PT
dc.language.isoengpt_PT
dc.publisherElsevierpt_PT
dc.relationinfo:eu-repo/grantAgreement/FCT/POR_NORTE/PD%2FBD%2F135452%2F2017/PT-
dc.relationinfo:eu-repo/grantAgreement/FCT/POR_NORTE/COVID%2FBD%2F152488%2F2022/PT-
dc.relation.ispartofseriesTrends in Immunologypt_PT
dc.rightsopenAccesspt_PT
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.titleGlycome dynamics in T and B cell development: basic immunological mechanisms and clinical applicationspt_PT
dc.typeArtigo em Revista Científica Internacionalpt_PT
dc.contributor.uportoInstituto de Investigação e Inovação em Saúdept_PT
dc.identifier.doi10.1016/j.it.2023.06.004-
dc.relation.publisherversionhttps://www.sciencedirect.com/science/article/pii/S1471490623001126-
Appears in Collections:I3S - Artigo em Revista Científica Internacional

Files in This Item:
File Description SizeFormat 
10.1016-j.it.2023.06.004.pdf682.42 kBAdobe PDFThumbnail
View/Open


This item is licensed under a Creative Commons License Creative Commons